In this week’s edition of InnovationRx, we look at how Hinge Health’s successful IPO may be a trendsetter, Indian billionaire ...

The positive reaction to Hinge Health’s initial public offering from Wall Street has brought optimism back to digital health.

Hinge Health leads in digital physiotherapy with strong ROI, sensor-free tech, and major growth potential in public and global markets. See why HNGE stock is a buy.

Investing in companies that have recently gone public is a strategy for individuals with a higher risk appetite. Typically, ...

Detailed price information for JP Morgan Chase & Company (JPM-N) from The Globe and Mail including charting and trades.

The CDC stopped recommending Covid shots for healthy children and pregnant women, while Hinge Health makes its debut on the ...

An increasing number of small-capitalization companies are going public this year despite the Russell 2000 Index’s ...

Digital therapeutics (DTx) developer Hinge Health has published a new prospectus for an initial public offering (IPO) in the US, shrugging off the weakness in stock markets caused by President ...

Omada Health updated its IPO prospectus on Thursday, indicating that it plans to raise up to $158 million in its offering.